Scientists originally created these medications for patients with type 2 diabetes, but the US Food and Drug Administration (FDA) has also approved them for weight loss in certain people
The anti-AKT (1:1000, ab227385), anti-phospho-AKT1 (Ser 473) (1:1000, ab81283), anti-FOXO3a (1:1000, ab12162), and anti-phospho-FOXO3a (Ser 253) (1:1000, ab154768) antibodies were purchased from Abcam Corp
PMID 21118657
Improved Overall Wellbeing: Some people experience heightened mood, cognition, and overall vitality
Our Re-Hydrate drip helps you feel rejuvenated and refreshed so you can get back to feeling your best
doi: 10.1097/MED.0000000000000616 105 LefvreC.Le RoyC.BessardA.Le Berre-ScoulC.MarchixJ.CoronE.et al